The microbiome and role of biofilms in Hidradenitis Suppurativa
Not Applicable
Completed
- Conditions
- Inflammatory and Immune System - Other inflammatory or immune system disordersInfection - Studies of infection and infectious agentsSkin - Dermatological conditionsHidradenitis suppurativa
- Registration Number
- ACTRN12619000802101
- Lead Sponsor
- iverpool Hospital, Department of Dermatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Inclusion criteria is the presence of hidradenitis suppurativa, diagnosed or having had the diagnosis confirmed by a dermatologist.
Exclusion Criteria
Patients will be excluded if they are less than 18 years of age.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine if biofilms are present in HS using microscopy.<br><br>[Single skin biopsies collection];Explore the microbial diversity, community structure and function (Microbiome) of HS and the differences between disease stages. This is a composite outcome. This will be assessed through the sampling of patients with lesions with different stages of the disease - Hurley stage I (mild), Hurley stage II (moderate) and Hurley stage III (severe) disease. This will also be assessed through the use of 16s and shotgun genomics. [Single skin biopsies collection]
- Secondary Outcome Measures
Name Time Method Explore associations between host- microbiome genes and inflammatory markers. This is an exploratory outcome, and will be assessed by the use of 16s and shotgun genomics.[Single skin biopsies collection];Assess the microbial load (number of bacteria) of HS. This will be assessed through the use of electron scanning microscopy.[Single skin biopsies collection];Assess the histopathology of HS specimens. This will be assessed through histopathological examination of the samples by a pathologist.[Single skin biopsies collection]